Trials / Completed
CompletedNCT05205226
Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment
Efficacy and Safety of Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment of Advanced Non-small Cell Lung Cancer: a Retrospective-real World Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 636 (actual)
- Sponsor
- Hunan Province Tumor Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aimed to confirmed that local radiotherapy for residual lesions can significantly prolong the efficacy of chemotherapy combined with immunotherapy in the initial treatment of advanced non-small cell lung cancer.
Conditions
Timeline
- Start date
- 2018-01-02
- Primary completion
- 2021-06-05
- Completion
- 2022-01-02
- First posted
- 2022-01-25
- Last updated
- 2022-01-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05205226. Inclusion in this directory is not an endorsement.